287 related articles for article (PubMed ID: 18788918)
1. Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer.
Jonklaas J; Nsouli-Maktabi H; Soldin SJ
Thyroid; 2008 Sep; 18(9):943-52. PubMed ID: 18788918
[TBL] [Abstract][Full Text] [Related]
2. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
Jonklaas J; Davidson B; Bhagat S; Soldin SJ
JAMA; 2008 Feb; 299(7):769-77. PubMed ID: 18285588
[TBL] [Abstract][Full Text] [Related]
3. TSH-suppressive doses of levothyroxine are required to achieve preoperative native serum triiodothyronine levels in patients who have undergone total thyroidectomy.
Ito M; Miyauchi A; Morita S; Kudo T; Nishihara E; Kihara M; Takamura Y; Ito Y; Kobayashi K; Miya A; Kubota S; Amino N
Eur J Endocrinol; 2012 Sep; 167(3):373-8. PubMed ID: 22711760
[TBL] [Abstract][Full Text] [Related]
4. Biochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy.
Ito M; Miyauchi A; Hisakado M; Yoshioka W; Ide A; Kudo T; Nishihara E; Kihara M; Ito Y; Kobayashi K; Miya A; Fukata S; Nishikawa M; Nakamura H; Amino N
Thyroid; 2017 Apr; 27(4):484-490. PubMed ID: 28056660
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of serum selenium, vitamin D, and thyrotropin concentrations in patients with thyroid cancer.
Jonklaas J; Danielsen M; Wang H
Thyroid; 2013 Sep; 23(9):1079-86. PubMed ID: 23350941
[TBL] [Abstract][Full Text] [Related]
6. Are endogenously lower serum thyroid hormones new predictors for thyroid malignancy in addition to higher serum thyrotropin?
Gul K; Ozdemir D; Dirikoc A; Oguz A; Tuzun D; Baser H; Ersoy R; Cakir B
Endocrine; 2010 Apr; 37(2):253-60. PubMed ID: 20960260
[TBL] [Abstract][Full Text] [Related]
7. Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma.
Wang LY; Smith AW; Palmer FL; Tuttle RM; Mahrous A; Nixon IJ; Patel SG; Ganly I; Fagin JA; Boucai L
Thyroid; 2015 Mar; 25(3):300-7. PubMed ID: 25386760
[TBL] [Abstract][Full Text] [Related]
8. Tandem mass spectrometry as a novel tool for elucidating pituitary-thyroid relationships.
Jonklaas J; Soldin SJ
Thyroid; 2008 Dec; 18(12):1303-11. PubMed ID: 19067639
[TBL] [Abstract][Full Text] [Related]
9. Higher TSH can be used as an additional risk factor in prediction of malignancy in euthyroid thyroid nodules evaluated by cytology based on Bethesda system.
Baser H; Topaloglu O; Tam AA; Evranos B; Alkan A; Sungu N; Dumlu EG; Ersoy R; Cakir B
Endocrine; 2016 Aug; 53(2):520-9. PubMed ID: 26972701
[TBL] [Abstract][Full Text] [Related]
10. Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer.
Lee MC; Kim MJ; Choi HS; Cho SW; Lee GH; Park YJ; Park DJ
Endocrinol Metab (Seoul); 2019 Jun; 34(2):150-157. PubMed ID: 31099202
[TBL] [Abstract][Full Text] [Related]
11. Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy.
Liewendahl K; Helenius T; Lamberg BA; Mähönen H; Wägar G
Acta Endocrinol (Copenh); 1987 Nov; 116(3):418-24. PubMed ID: 3687325
[TBL] [Abstract][Full Text] [Related]
12. Preoperative serum thyroid stimulating hormone levels in well-differentiated thyroid carcinoma is a predictive factor for lateral lymph node metastasis as well as extrathyroidal extension in Korean patients: a single-center experience.
Kim SS; Lee BJ; Lee JC; Song SH; Kim BH; Son SM; Kim IJ; Kim YK; Kang YH
Endocrine; 2011 Jun; 39(3):259-65. PubMed ID: 21161440
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
[TBL] [Abstract][Full Text] [Related]
14. Thyroid function related symptoms during levothyroxine monotherapy in athyreotic patients.
Ito M; Miyauchi A; Hisakado M; Yoshioka W; Kudo T; Nishihara E; Kihara M; Ito Y; Miya A; Fukata S; Nishikawa M; Nakamura H
Endocr J; 2019 Nov; 66(11):953-960. PubMed ID: 31270299
[TBL] [Abstract][Full Text] [Related]
15. THE ASSOCIATION OF THYROID HORMONES AND TSH WITH THE METABOLIC SYNDROME IN EUTHYROID TAIWANESE INDIVIDUALS.
Huang CY; Hwang LC
Endocr Pract; 2016 Nov; 22(11):1303-1309. PubMed ID: 27482612
[TBL] [Abstract][Full Text] [Related]
16. Thyroid hormone levels associated with active and passive cigarette smoking.
Soldin OP; Goughenour BE; Gilbert SZ; Landy HJ; Soldin SJ
Thyroid; 2009 Aug; 19(8):817-23. PubMed ID: 19505184
[TBL] [Abstract][Full Text] [Related]
17. Comparison of pathophysiology in subclinical hyperthyroidism with different etiologies.
Deguchi-Horiuchi H; Ito M; Takahashi S; Kousaka K; Hisakado M; Fukata S; Kudo T; Nishihara E; Nishikawa M; Miyauchi A; Akamizu T
Endocr J; 2024 Apr; 71(4):373-381. PubMed ID: 38296546
[TBL] [Abstract][Full Text] [Related]
18. Correlation of TSH with the risk of paediatric thyroid carcinoma.
Chiu HK; Sanda S; Fechner PY; Pihoker C
Clin Endocrinol (Oxf); 2012 Aug; 77(2):316-22. PubMed ID: 22404106
[TBL] [Abstract][Full Text] [Related]
19. Levothyroxine dose requirements for thyrotropin suppression in the treatment of differentiated thyroid cancer.
Burmeister LA; Goumaz MO; Mariash CN; Oppenheimer JH
J Clin Endocrinol Metab; 1992 Aug; 75(2):344-50. PubMed ID: 1639933
[TBL] [Abstract][Full Text] [Related]
20. Effects of endocrine therapy on the prognosis of elderly patients after surgery for papillary thyroid carcinoma.
Xia Q; Dong S; Bian PD; Wang J; Li CJ
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1037-43. PubMed ID: 25744048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]